Benzinga··Akanksha BakshiGeoVax Surges on Ebola Platform Push Amid WHO Emergency Alert
$GOVX rallies 16% on MVA vaccine platform potential for Ebola threats and WHO emergency declaration. Phase 3 trials planned for Q4 2026.
GOVXclinical-stage biotechprivate placement